©The Author(s) 2025.
World J Gastroenterol. Sep 28, 2025; 31(36): 109143
Published online Sep 28, 2025. doi: 10.3748/wjg.v31.i36.109143
Published online Sep 28, 2025. doi: 10.3748/wjg.v31.i36.109143
Table 8 Available randomised studies on the dietary emulsifier restriction and their effect
| Ref. | Type of study | Population characteristics, n | Outcome parameters | Key findings |
| Bhattacharyya et al[125], 2017 | RCT | Cases (n = 5): UC in remission on 100mg carrageenan-containing capsule; Controls (n = 7): UC in remission on placebo capsules | Relapse in two groups at different time points (3, 6, 9, and 12 months); Relapse is defined as an increase of two (or more) points on the SCCAI | Relapses were higher with the carrageenan diet (P = 0.046); Increase in interleukin-6 (P = 0.02) and fecal calprotectin (P = 0.06) in carrageenan diet group |
| Chassaing et al[126], 2022 | RCT | Cases (n = 7): Diet enriched with 15 g/day of CMC; Controls (n = 9): Emulsifier-free diets | Metabolic impact in healthy volunteers: Effect on human gut microbiota composition and gene expression | CMC reduced microbiota richness with a decrease in evenness and Shannon indices; CMC consumption affected the fecal metabolome with depletion of short-chain fatty acids and free amino acids |
| Fitzpatrick et al[127], 2025 | RCT | HED (n = 12) vs LED (n = 12) was provided for 4 weeks in patients with CD | The emulsifier content did not influence disease activity in CD | |
| Bancil et al[128], 2025 | Multicentric RCT | LED (n = 75) vs LED plus emulsifier re-supplementation (Controls, n = 79) was provided for 8 weeks in active CD | Primary endpoint: Proportion of patients achieving CDAI response (≥ 70 reduction) at 8 weeks; Secondary endpoint: CDAI remission and fecal calprotectin | CDAI response was achieved in 39 (49.4%) on LED vs 23 (30.7%) in the control group (P = 0.019); Patients on LED are more than twice as likely to experience CDAI remission (adjusted RR: 2.1, 95%CI: 1.0-4.42) and > 50% reduction in FCP (adjusted RR: 2.9, 95%CI: 1.1-8.0) |
- Citation: Singh AK, Gandotra A, Kumar S, Singh A, Kochhar R, Manrai M. Ultra-processed foods: Implications for gastrointestinal health. World J Gastroenterol 2025; 31(36): 109143
- URL: https://www.wjgnet.com/1007-9327/full/v31/i36/109143.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i36.109143